There has been a particular antiviral pill discovered, one that allegedly can reduce the risk of being hospitalized or dying of the virus by 50%. The pill has been announced by the pharmaceutical companies Merck and Ridgeback, and it would require an administration over five days, shortly after COVID-19 diagnosis.
The pill is called molnupiravir, and it needs the ultimate authorization from the Food and Drug Administration, to become the first antiviral pill people can take at home to reduce the risk of developing severe forms of this illness. It could be a versatile tool for doctors in the battle against Covid-19, and could ultimately save many lives.
